The prognostic significance of microsatellite instability in colorectal cancer: a Swedish multi-center study

Purpose About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI). Previous reports of colorectal cancer (CRC) indicate a better prognosis for patients with MSI tumors compared to patients with microsate...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of colorectal disease Vol. 38; no. 1; p. 197
Main Authors Rantanen, Petri, Keränen, Anne, Barot, Shabane, Ghazi, Sam, Liljegren, Annelie, Nordenvall, Caroline, Lindblom, Annika, Lindforss, Ulrik
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 17.07.2023
Springer
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI). Previous reports of colorectal cancer (CRC) indicate a better prognosis for patients with MSI tumors compared to patients with microsatellite stable (MSS) tumors. In this study, our aim was to investigate whether MSI is an independent prognostic factor in CRC. Patients and methods Patients with stage I–III colorectal cancer and subject to curative surgery during 2002–2006 in the Swedish low-risk colorectal cancer study group cohort were eligible for inclusion. Deficient MMR (dMMR) status was analyzed by immunohistochemistry (IHC) and/or by MSI testing with polymerase chain reaction (PCR). Prognostic follow-up and treatment data were retrieved from patient records. Statistical analyses to assess MSI-status and prognosis were done using logistic regression and survival analyses using the Kaplan-Meier method and Cox regression hazards models adjusted for age, sex, stage, comorbidity, and tumor location. Results In total, 463 patients were included, MSI high tumors were present in 66 patients (14%), and the remaining 397 were MSS/MSI low. Within 6 years, distant recurrences were present in 9.1% and 20.2% ( P  = 0.049), and death occurred in 25.8% and 31.5% in MSI and MSS patients, respectively. There was no statistically significant difference in overall mortality (HR 0.80, 95% CI 0.46–1.38), relapse-free survival (HR 0.82, 95% CI 0.50–1.36), or cancer-specific mortality (HR 1.60, 95% CI 0.73–3.51). Conclusion Despite distant metastases being less common in patients with MSI, there was no association between MSI and overall, relapse-free, or cancer-specific survival.
AbstractList About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI). Previous reports of colorectal cancer (CRC) indicate a better prognosis for patients with MSI tumors compared to patients with microsatellite stable (MSS) tumors. In this study, our aim was to investigate whether MSI is an independent prognostic factor in CRC.PURPOSEAbout 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI). Previous reports of colorectal cancer (CRC) indicate a better prognosis for patients with MSI tumors compared to patients with microsatellite stable (MSS) tumors. In this study, our aim was to investigate whether MSI is an independent prognostic factor in CRC.Patients with stage I-III colorectal cancer and subject to curative surgery during 2002-2006 in the Swedish low-risk colorectal cancer study group cohort were eligible for inclusion. Deficient MMR (dMMR) status was analyzed by immunohistochemistry (IHC) and/or by MSI testing with polymerase chain reaction (PCR). Prognostic follow-up and treatment data were retrieved from patient records. Statistical analyses to assess MSI-status and prognosis were done using logistic regression and survival analyses using the Kaplan-Meier method and Cox regression hazards models adjusted for age, sex, stage, comorbidity, and tumor location.PATIENTS AND METHODSPatients with stage I-III colorectal cancer and subject to curative surgery during 2002-2006 in the Swedish low-risk colorectal cancer study group cohort were eligible for inclusion. Deficient MMR (dMMR) status was analyzed by immunohistochemistry (IHC) and/or by MSI testing with polymerase chain reaction (PCR). Prognostic follow-up and treatment data were retrieved from patient records. Statistical analyses to assess MSI-status and prognosis were done using logistic regression and survival analyses using the Kaplan-Meier method and Cox regression hazards models adjusted for age, sex, stage, comorbidity, and tumor location.In total, 463 patients were included, MSI high tumors were present in 66 patients (14%), and the remaining 397 were MSS/MSI low. Within 6 years, distant recurrences were present in 9.1% and 20.2% (P = 0.049), and death occurred in 25.8% and 31.5% in MSI and MSS patients, respectively. There was no statistically significant difference in overall mortality (HR 0.80, 95% CI 0.46-1.38), relapse-free survival (HR 0.82, 95% CI 0.50-1.36), or cancer-specific mortality (HR 1.60, 95% CI 0.73-3.51).RESULTSIn total, 463 patients were included, MSI high tumors were present in 66 patients (14%), and the remaining 397 were MSS/MSI low. Within 6 years, distant recurrences were present in 9.1% and 20.2% (P = 0.049), and death occurred in 25.8% and 31.5% in MSI and MSS patients, respectively. There was no statistically significant difference in overall mortality (HR 0.80, 95% CI 0.46-1.38), relapse-free survival (HR 0.82, 95% CI 0.50-1.36), or cancer-specific mortality (HR 1.60, 95% CI 0.73-3.51).Despite distant metastases being less common in patients with MSI, there was no association between MSI and overall, relapse-free, or cancer-specific survival.CONCLUSIONDespite distant metastases being less common in patients with MSI, there was no association between MSI and overall, relapse-free, or cancer-specific survival.
Purpose About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI). Previous reports of colorectal cancer (CRC) indicate a better prognosis for patients with MSI tumors compared to patients with microsatellite stable (MSS) tumors. In this study, our aim was to investigate whether MSI is an independent prognostic factor in CRC. Patients and methods Patients with stage I–III colorectal cancer and subject to curative surgery during 2002–2006 in the Swedish low-risk colorectal cancer study group cohort were eligible for inclusion. Deficient MMR (dMMR) status was analyzed by immunohistochemistry (IHC) and/or by MSI testing with polymerase chain reaction (PCR). Prognostic follow-up and treatment data were retrieved from patient records. Statistical analyses to assess MSI-status and prognosis were done using logistic regression and survival analyses using the Kaplan-Meier method and Cox regression hazards models adjusted for age, sex, stage, comorbidity, and tumor location. Results In total, 463 patients were included, MSI high tumors were present in 66 patients (14%), and the remaining 397 were MSS/MSI low. Within 6 years, distant recurrences were present in 9.1% and 20.2% ( P  = 0.049), and death occurred in 25.8% and 31.5% in MSI and MSS patients, respectively. There was no statistically significant difference in overall mortality (HR 0.80, 95% CI 0.46–1.38), relapse-free survival (HR 0.82, 95% CI 0.50–1.36), or cancer-specific mortality (HR 1.60, 95% CI 0.73–3.51). Conclusion Despite distant metastases being less common in patients with MSI, there was no association between MSI and overall, relapse-free, or cancer-specific survival.
Purpose About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI). Previous reports of colorectal cancer (CRC) indicate a better prognosis for patients with MSI tumors compared to patients with microsatellite stable (MSS) tumors. In this study, our aim was to investigate whether MSI is an independent prognostic factor in CRC. Patients and methods Patients with stage I-III colorectal cancer and subject to curative surgery during 2002-2006 in the Swedish low-risk colorectal cancer study group cohort were eligible for inclusion. Deficient MMR (dMMR) status was analyzed by immunohistochemistry (IHC) and/or by MSI testing with polymerase chain reaction (PCR). Prognostic follow-up and treatment data were retrieved from patient records. Statistical analyses to assess MSI-status and prognosis were done using logistic regression and survival analyses using the Kaplan-Meier method and Cox regression hazards models adjusted for age, sex, stage, comorbidity, and tumor location. Results In total, 463 patients were included, MSI high tumors were present in 66 patients (14%), and the remaining 397 were MSS/MSI low. Within 6 years, distant recurrences were present in 9.1% and 20.2% (P = 0.049), and death occurred in 25.8% and 31.5% in MSI and MSS patients, respectively. There was no statistically significant difference in overall mortality (HR 0.80, 95% CI 0.46-1.38), relapse-free survival (HR 0.82, 95% CI 0.50-1.36), or cancer-specific mortality (HR 1.60, 95% CI 0.73-3.51). Conclusion Despite distant metastases being less common in patients with MSI, there was no association between MSI and overall, relapse-free, or cancer-specific survival.
About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI). Previous reports of colorectal cancer (CRC) indicate a better prognosis for patients with MSI tumors compared to patients with microsatellite stable (MSS) tumors. In this study, our aim was to investigate whether MSI is an independent prognostic factor in CRC. In total, 463 patients were included, MSI high tumors were present in 66 patients (14%), and the remaining 397 were MSS/MSI low. Within 6 years, distant recurrences were present in 9.1% and 20.2% (P = 0.049), and death occurred in 25.8% and 31.5% in MSI and MSS patients, respectively. There was no statistically significant difference in overall mortality (HR 0.80, 95% CI 0.46-1.38), relapse-free survival (HR 0.82, 95% CI 0.50-1.36), or cancer-specific mortality (HR 1.60, 95% CI 0.73-3.51). Despite distant metastases being less common in patients with MSI, there was no association between MSI and overall, relapse-free, or cancer-specific survival.
About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI). Previous reports of colorectal cancer (CRC) indicate a better prognosis for patients with MSI tumors compared to patients with microsatellite stable (MSS) tumors. In this study, our aim was to investigate whether MSI is an independent prognostic factor in CRC. Patients with stage I-III colorectal cancer and subject to curative surgery during 2002-2006 in the Swedish low-risk colorectal cancer study group cohort were eligible for inclusion. Deficient MMR (dMMR) status was analyzed by immunohistochemistry (IHC) and/or by MSI testing with polymerase chain reaction (PCR). Prognostic follow-up and treatment data were retrieved from patient records. Statistical analyses to assess MSI-status and prognosis were done using logistic regression and survival analyses using the Kaplan-Meier method and Cox regression hazards models adjusted for age, sex, stage, comorbidity, and tumor location. In total, 463 patients were included, MSI high tumors were present in 66 patients (14%), and the remaining 397 were MSS/MSI low. Within 6 years, distant recurrences were present in 9.1% and 20.2% (P = 0.049), and death occurred in 25.8% and 31.5% in MSI and MSS patients, respectively. There was no statistically significant difference in overall mortality (HR 0.80, 95% CI 0.46-1.38), relapse-free survival (HR 0.82, 95% CI 0.50-1.36), or cancer-specific mortality (HR 1.60, 95% CI 0.73-3.51). Despite distant metastases being less common in patients with MSI, there was no association between MSI and overall, relapse-free, or cancer-specific survival.
ArticleNumber 197
Audience Academic
Author Ghazi, Sam
Lindforss, Ulrik
Nordenvall, Caroline
Lindblom, Annika
Barot, Shabane
Liljegren, Annelie
Rantanen, Petri
Keränen, Anne
Author_xml – sequence: 1
  givenname: Petri
  surname: Rantanen
  fullname: Rantanen, Petri
  email: petri.rantanen@ki.se
  organization: Department of Molecular Medicine and Surgery, Karolinska Institutet
– sequence: 2
  givenname: Anne
  surname: Keränen
  fullname: Keränen, Anne
  organization: Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet
– sequence: 3
  givenname: Shabane
  surname: Barot
  fullname: Barot, Shabane
  organization: Department of Clinical Science and Education, Södersjukhuset
– sequence: 4
  givenname: Sam
  surname: Ghazi
  fullname: Ghazi, Sam
  organization: Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet
– sequence: 5
  givenname: Annelie
  surname: Liljegren
  fullname: Liljegren, Annelie
  organization: Department of Oncology-Pathology, Karolinska Institutet
– sequence: 6
  givenname: Caroline
  surname: Nordenvall
  fullname: Nordenvall, Caroline
  organization: Department of Molecular Medicine and Surgery, Karolinska Institutet
– sequence: 7
  givenname: Annika
  surname: Lindblom
  fullname: Lindblom, Annika
  organization: Department of Molecular Medicine and Surgery, Karolinska Institutet, Department of Clinical Genetics, Karolinska Institutet
– sequence: 8
  givenname: Ulrik
  surname: Lindforss
  fullname: Lindforss, Ulrik
  organization: Department of Molecular Medicine and Surgery, Karolinska Institutet
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37458848$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:153300967$$DView record from Swedish Publication Index
BookMark eNp9kktv1DAUhSNURB_wB1ggS2zYpPgZu2xQVfGSKrGgrC3Hucm4ZOzBdlpNfz1OM1QdhCovfGV_5-bG5xxXBz54qKrXBJ8SjOX7hDFTvMaU1Zhzheu7Z9UR4YzWhDb04FF9WB2ndI0xkY3kL6pDJrlQiqujarxaAdrEMPiQsrMoucG73lnjLaDQo7WzMSSTYRxdBuR8yqZ1pd6WGtkwhgg2mxHdK-IHZNCPW-hcWqH1NGZXW_AZIkp56rYvq-e9GRO82u0n1c_Pn64uvtaX3798uzi_rK0QNNeNBNJ2Hek4l4opg0XTkra1WLYcc0mE6LFpqGrYWc9bIlTHKdDW8o5Qijmwk6pe-qZb2Eyt3kS3NnGrg3F6d_SrVKAbzqSihf-48OVmDd08cjTjnmz_xruVHsKNJpgJShpWOrzbdYjh9wQp67VLtjya8RCmpKliZ5Q3jRIFfbuggxlBO9-H0tLOuD6XQgrFKJlHOv0PVVYHxZKSg96V8z3Bm8f_8DD8X6sLQBdgNjRF6B8QgvWcJ73kSZc86fs86bsiUv-IrMsmuzC_gxuflrKdCeU7foCor8MUffH9KdUf_gXhFQ
CitedBy_id crossref_primary_10_1080_13102818_2024_2356864
Cites_doi 10.1038/363558a0
10.1126/science.8484121
10.1200/JCO.2006.05.8172
10.1038/sj.bjc.6602534
10.1158/1055-9965.EPI-08-0512
10.1038/sj.bjc.6690676
10.1007/s00384-006-0131-8
10.1200/JCO.2009.27.1825
10.1200/JCO.2010.30.1366
10.1200/JCO.2005.01.086
10.1080/00365521.2018.1542453
10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.0.CO;2-S
10.1016/j.ejca.2010.05.009
10.1038/nrclinonc.2009.237
10.1136/gut.42.5.673
10.3393/ac.2014.30.1.28
10.1200/JCO.2005.03.2433
10.1016/j.ejca.2009.04.018
10.1200/JCO.2008.17.5950
10.1093/jnci/djr153
10.1126/science.8484122
10.1093/annonc/mds614
10.1126/science.aan6733
10.2353/ajpath.2010.100298
10.1038/s41379-018-0094-7
10.21873/anticanres.11518
10.1136/gut.48.6.821
10.1053/j.gastro.2006.06.005
10.1200/jco.2014.32.15_suppl.3507
10.1093/jnci/91.15.1295
10.2353/jmoldx.2008.080031
10.1200/jco.2009.27.15_suppl.4001
10.1200/jco.2009.27.15_suppl.4002
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
COPYRIGHT 2023 Springer
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 Springer
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTPV
AOWAS
D8T
ZZAVC
DOI 10.1007/s00384-023-04480-z
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Freely available online
SwePub Articles full text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1262
ExternalDocumentID oai_swepub_ki_se_643782
PMC10352163
A757583212
37458848
10_1007_s00384_023_04480_z
Genre Multicenter Study
Journal Article
GeographicLocations Sweden
GeographicLocations_xml – name: Sweden
GrantInformation_xml – fundername: Karolinska Institute
– fundername: ;
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29J
29~
2J2
2JN
2JY
2KG
2LR
2~H
30V
36B
4.4
406
408
409
40D
40E
5GY
5RE
5VS
67Z
6NX
7X7
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAHNG
AAIAL
AAJKR
AAJSJ
AAKKN
AANZL
AARTL
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABEEZ
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AITGF
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BENPR
BGNMA
BPHCQ
BVXVI
C6C
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EMB
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FNLPD
FRRFC
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M4Y
MA-
N9A
NB0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PQQKQ
PROAC
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
ROL
RPX
RRX
RSV
S16
S27
S37
S3B
SAP
SDH
SDM
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UOJIU
UTJUX
VC2
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7V
Z7W
Z7X
Z82
Z87
Z8O
Z8P
Z8Q
Z8V
Z91
ZMTXR
ZOVNA
~EX
~KM
AASML
AAYXX
ABDBE
ABFSG
ACSTC
AEZWR
AFGXO
AFHIU
AHPBZ
AHWEU
AIXLP
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
7X8
5PM
-Y2
.GJ
1SB
2.D
28-
2P1
2VQ
53G
5QI
88E
8AO
8FI
8FJ
AAFWJ
AANXM
AARHV
AAYTO
ABQSL
ABUWG
ACACY
ACBXY
ACUDM
ACULB
ADHKG
ADTPV
AEBTG
AEFIE
AEKMD
AFDYV
AFEXP
AFKRA
AGGDS
AGQPQ
AJBLW
AOWAS
BBWZM
BDATZ
C24
CAG
CCPQU
COF
D8T
EJD
EN4
FINBP
FSGXE
GRRUI
H13
HMCUK
KOW
M1P
N2Q
NDZJH
O9-
PHGZM
PHGZT
PJZUB
PPXIY
PSQYO
PUEGO
R4E
RNI
RZK
S1Z
S26
S28
SCLPG
SDE
T16
UKHRP
UZXMN
VFIZW
ZZAVC
ID FETCH-LOGICAL-c552t-67e1bdd1d447838a056b1bbc07b4047155f0a628639f4b158d42e2bc4d12204e3
IEDL.DBID U2A
ISSN 1432-1262
0179-1958
IngestDate Mon Aug 25 03:39:08 EDT 2025
Thu Aug 21 18:36:27 EDT 2025
Fri Jul 11 16:23:55 EDT 2025
Tue Jun 17 22:03:06 EDT 2025
Tue Jun 10 21:06:27 EDT 2025
Wed Feb 19 02:05:50 EST 2025
Thu Apr 24 22:56:33 EDT 2025
Tue Jul 01 04:24:40 EDT 2025
Fri Feb 21 02:41:03 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Prognosis
Microsatellite instability
Mismatch repair
Colorectal cancer
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c552t-67e1bdd1d447838a056b1bbc07b4047155f0a628639f4b158d42e2bc4d12204e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://link.springer.com/10.1007/s00384-023-04480-z
PMID 37458848
PQID 2839246685
PQPubID 23479
ParticipantIDs swepub_primary_oai_swepub_ki_se_643782
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10352163
proquest_miscellaneous_2839246685
gale_infotracmisc_A757583212
gale_infotracacademiconefile_A757583212
pubmed_primary_37458848
crossref_primary_10_1007_s00384_023_04480_z
crossref_citationtrail_10_1007_s00384_023_04480_z
springer_journals_10_1007_s00384_023_04480_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-07-17
PublicationDateYYYYMMDD 2023-07-17
PublicationDate_xml – month: 07
  year: 2023
  text: 2023-07-17
  day: 17
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
PublicationSubtitle Clinical and Molecular Gastroenterology and Surgery
PublicationTitle International journal of colorectal disease
PublicationTitleAbbrev Int J Colorectal Dis
PublicationTitleAlternate Int J Colorectal Dis
PublicationYear 2023
Publisher Springer Berlin Heidelberg
Springer
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer
References Ward (CR7) 2001; 48
Peltomäki (CR4) 1993; 53
Vilar, Gruber (CR8) 2010; 7
CR19
Sinicrope (CR20) 2011; 103
CR17
Ghazi (CR23) 2010; 177
Shin (CR31) 2014; 30
Hutchins (CR32) 2011; 29
Hissong (CR11) 2018; 31
CR15
Ionov (CR2) 1993; 363
Poynter (CR5) 2008; 17
CR12
Lanza (CR16) 2006; 24
CR33
Guastadisegni (CR26) 2010; 46
Hampel (CR6) 2008; 26
Salahshor (CR29) 1999; 81
Jass (CR9) 1998; 42
Lamberti (CR28) 2007; 22
Aaltonen (CR3) 1993; 260
Sinicrope (CR13) 2006; 131
Merok (CR30) 2013; 24
Des Guetz (CR21) 2009; 45
Thibodeau, Bren, Schaid (CR1) 1993; 260
Forsberg (CR22) 2017; 37
Le (CR34) 2017; 357
Buckowitz (CR35) 2005; 92
Gafà (CR14) 2000; 89
Popat, Hubner, Houlston (CR25) 2005; 23
Cheah (CR10) 2019; 41
Sargent (CR18) 2010; 28
Keränen (CR24) 2018; 53
Kim (CR27) 2007; 25
A Buckowitz (4480_CR35) 2005; 92
MA Merok (4480_CR30) 2013; 24
DT Le (4480_CR34) 2017; 357
FA Sinicrope (4480_CR13) 2006; 131
SN Thibodeau (4480_CR1) 1993; 260
C Lamberti (4480_CR28) 2007; 22
C Guastadisegni (4480_CR26) 2010; 46
P Peltomäki (4480_CR4) 1993; 53
DJ Sargent (4480_CR18) 2010; 28
Y Ionov (4480_CR2) 1993; 363
R Gafà (4480_CR14) 2000; 89
S Salahshor (4480_CR29) 1999; 81
H Hampel (4480_CR6) 2008; 26
G Lanza (4480_CR16) 2006; 24
A Forsberg (4480_CR22) 2017; 37
FA Sinicrope (4480_CR20) 2011; 103
G Des Guetz (4480_CR21) 2009; 45
S Popat (4480_CR25) 2005; 23
GP Kim (4480_CR27) 2007; 25
S Ghazi (4480_CR23) 2010; 177
JR Jass (4480_CR9) 1998; 42
US Shin (4480_CR31) 2014; 30
G Hutchins (4480_CR32) 2011; 29
E Vilar (4480_CR8) 2010; 7
R Ward (4480_CR7) 2001; 48
A Keränen (4480_CR24) 2018; 53
E Hissong (4480_CR11) 2018; 31
4480_CR12
4480_CR33
PL Cheah (4480_CR10) 2019; 41
4480_CR15
JN Poynter (4480_CR5) 2008; 17
4480_CR19
LA Aaltonen (4480_CR3) 1993; 260
4480_CR17
References_xml – volume: 53
  start-page: 5853
  issue: 24
  year: 1993
  end-page: 5855
  ident: CR4
  article-title: Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome1
  publication-title: Can Res
– volume: 363
  start-page: 558
  issue: 6429
  year: 1993
  end-page: 561
  ident: CR2
  article-title: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
  publication-title: Nature
  doi: 10.1038/363558a0
– volume: 260
  start-page: 812
  issue: 5109
  year: 1993
  end-page: 816
  ident: CR3
  article-title: Clues to the pathogenesis of familial colorectal cancer
  publication-title: Science
  doi: 10.1126/science.8484121
– volume: 25
  start-page: 767
  issue: 7
  year: 2007
  end-page: 772
  ident: CR27
  article-title: Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a national cancer institute–national surgical adjuvant breast and bowel project collaborative study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.05.8172
– volume: 92
  start-page: 1746
  issue: 9
  year: 2005
  end-page: 1753
  ident: CR35
  article-title: Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602534
– volume: 17
  start-page: 3208
  issue: 11
  year: 2008
  end-page: 3215
  ident: CR5
  article-title: Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening
  publication-title: Cancer Epidemiol Biomark Prev
  doi: 10.1158/1055-9965.EPI-08-0512
– volume: 81
  start-page: 190
  issue: 2
  year: 1999
  end-page: 193
  ident: CR29
  article-title: Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6690676
– ident: CR12
– volume: 22
  start-page: 145
  issue: 2
  year: 2007
  end-page: 152
  ident: CR28
  article-title: Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-006-0131-8
– ident: CR33
– volume: 28
  start-page: 3219
  issue: 20
  year: 2010
  end-page: 3226
  ident: CR18
  article-title: Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.27.1825
– volume: 29
  start-page: 1261
  issue: 10
  year: 2011
  end-page: 1270
  ident: CR32
  article-title: Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.30.1366
– volume: 23
  start-page: 609
  issue: 3
  year: 2005
  end-page: 618
  ident: CR25
  article-title: Systematic review of microsatellite instability and colorectal cancer prognosis
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.01.086
– volume: 53
  start-page: 1535
  issue: 12
  year: 2018
  end-page: 1540
  ident: CR24
  article-title: Testing strategies to reduce morbidity and mortality from Lynch syndrome
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2018.1542453
– volume: 89
  start-page: 2025
  issue: 10
  year: 2000
  end-page: 2037
  ident: CR14
  article-title: Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability
  publication-title: Cancer
  doi: 10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.0.CO;2-S
– volume: 46
  start-page: 2788
  issue: 15
  year: 2010
  end-page: 2798
  ident: CR26
  article-title: Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2010.05.009
– ident: CR19
– volume: 7
  start-page: 153
  issue: 3
  year: 2010
  end-page: 162
  ident: CR8
  article-title: Microsatellite instability in colorectal cancer-the stable evidence
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2009.237
– volume: 42
  start-page: 673
  issue: 5
  year: 1998
  end-page: 679
  ident: CR9
  article-title: Morphology of sporadic colorectal cancer with DNA replication errors
  publication-title: Gut
  doi: 10.1136/gut.42.5.673
– ident: CR15
– volume: 30
  start-page: 28
  issue: 1
  year: 2014
  end-page: 34
  ident: CR31
  article-title: Is microsatellite instability really a good prognostic factor of colorectal cancer?
  publication-title: Ann Coloproctol
  doi: 10.3393/ac.2014.30.1.28
– ident: CR17
– volume: 24
  start-page: 2359
  issue: 15
  year: 2006
  end-page: 2367
  ident: CR16
  article-title: Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.03.2433
– volume: 45
  start-page: 1890
  issue: 10
  year: 2009
  end-page: 1896
  ident: CR21
  article-title: Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2009.04.018
– volume: 41
  start-page: 91
  issue: 2
  year: 2019
  end-page: 100
  ident: CR10
  article-title: Screening for microsatellite instability in colorectal carcinoma: practical utility of immunohistochemistry and PCR with fragment analysis in a diagnostic histopathology setting
  publication-title: Malays J Pathol
– volume: 26
  start-page: 5783
  issue: 35
  year: 2008
  end-page: 5788
  ident: CR6
  article-title: Feasibility of screening for lynch syndrome among patients with colorectal cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.17.5950
– volume: 103
  start-page: 863
  issue: 11
  year: 2011
  end-page: 875
  ident: CR20
  article-title: DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djr153
– volume: 260
  start-page: 816
  issue: 5109
  year: 1993
  end-page: 819
  ident: CR1
  article-title: Microsatellite instability in cancer of the proximal colon
  publication-title: Science
  doi: 10.1126/science.8484122
– volume: 24
  start-page: 1274
  issue: 5
  year: 2013
  end-page: 1282
  ident: CR30
  article-title: Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mds614
– volume: 357
  start-page: 409
  issue: 6349
  year: 2017
  end-page: 413
  ident: CR34
  article-title: Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
  publication-title: Science
  doi: 10.1126/science.aan6733
– volume: 177
  start-page: 2688
  issue: 6
  year: 2010
  end-page: 2693
  ident: CR23
  article-title: Colorectal cancer susceptibility loci in a population-based study
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2010.100298
– volume: 31
  start-page: 1756
  issue: 11
  year: 2018
  end-page: 1766
  ident: CR11
  article-title: Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing
  publication-title: Mod Pathol
  doi: 10.1038/s41379-018-0094-7
– volume: 37
  start-page: 1831
  issue: 4
  year: 2017
  end-page: 1835
  ident: CR22
  article-title: Defining new colorectal cancer syndromes in a population-based cohort of the disease
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.11518
– volume: 48
  start-page: 821
  issue: 6
  year: 2001
  end-page: 829
  ident: CR7
  article-title: Microsatellite instability and the clinicopathological features of sporadic colorectal cancer
  publication-title: Gut
  doi: 10.1136/gut.48.6.821
– volume: 131
  start-page: 729
  issue: 3
  year: 2006
  end-page: 737
  ident: CR13
  article-title: Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2006.06.005
– volume: 131
  start-page: 729
  issue: 3
  year: 2006
  ident: 4480_CR13
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2006.06.005
– volume: 22
  start-page: 145
  issue: 2
  year: 2007
  ident: 4480_CR28
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-006-0131-8
– ident: 4480_CR17
  doi: 10.1200/jco.2014.32.15_suppl.3507
– volume: 81
  start-page: 190
  issue: 2
  year: 1999
  ident: 4480_CR29
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6690676
– volume: 31
  start-page: 1756
  issue: 11
  year: 2018
  ident: 4480_CR11
  publication-title: Mod Pathol
  doi: 10.1038/s41379-018-0094-7
– volume: 29
  start-page: 1261
  issue: 10
  year: 2011
  ident: 4480_CR32
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.30.1366
– volume: 53
  start-page: 5853
  issue: 24
  year: 1993
  ident: 4480_CR4
  publication-title: Can Res
– volume: 363
  start-page: 558
  issue: 6429
  year: 1993
  ident: 4480_CR2
  publication-title: Nature
  doi: 10.1038/363558a0
– volume: 41
  start-page: 91
  issue: 2
  year: 2019
  ident: 4480_CR10
  publication-title: Malays J Pathol
– volume: 357
  start-page: 409
  issue: 6349
  year: 2017
  ident: 4480_CR34
  publication-title: Science
  doi: 10.1126/science.aan6733
– ident: 4480_CR15
  doi: 10.1093/jnci/91.15.1295
– volume: 260
  start-page: 812
  issue: 5109
  year: 1993
  ident: 4480_CR3
  publication-title: Science
  doi: 10.1126/science.8484121
– volume: 260
  start-page: 816
  issue: 5109
  year: 1993
  ident: 4480_CR1
  publication-title: Science
  doi: 10.1126/science.8484122
– ident: 4480_CR12
  doi: 10.2353/jmoldx.2008.080031
– volume: 89
  start-page: 2025
  issue: 10
  year: 2000
  ident: 4480_CR14
  publication-title: Cancer
  doi: 10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.0.CO;2-S
– ident: 4480_CR19
  doi: 10.1200/jco.2009.27.15_suppl.4001
– volume: 25
  start-page: 767
  issue: 7
  year: 2007
  ident: 4480_CR27
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.05.8172
– volume: 45
  start-page: 1890
  issue: 10
  year: 2009
  ident: 4480_CR21
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2009.04.018
– volume: 7
  start-page: 153
  issue: 3
  year: 2010
  ident: 4480_CR8
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2009.237
– volume: 26
  start-page: 5783
  issue: 35
  year: 2008
  ident: 4480_CR6
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.17.5950
– volume: 17
  start-page: 3208
  issue: 11
  year: 2008
  ident: 4480_CR5
  publication-title: Cancer Epidemiol Biomark Prev
  doi: 10.1158/1055-9965.EPI-08-0512
– volume: 24
  start-page: 2359
  issue: 15
  year: 2006
  ident: 4480_CR16
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.03.2433
– volume: 46
  start-page: 2788
  issue: 15
  year: 2010
  ident: 4480_CR26
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2010.05.009
– volume: 42
  start-page: 673
  issue: 5
  year: 1998
  ident: 4480_CR9
  publication-title: Gut
  doi: 10.1136/gut.42.5.673
– volume: 24
  start-page: 1274
  issue: 5
  year: 2013
  ident: 4480_CR30
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mds614
– volume: 30
  start-page: 28
  issue: 1
  year: 2014
  ident: 4480_CR31
  publication-title: Ann Coloproctol
  doi: 10.3393/ac.2014.30.1.28
– volume: 48
  start-page: 821
  issue: 6
  year: 2001
  ident: 4480_CR7
  publication-title: Gut
  doi: 10.1136/gut.48.6.821
– volume: 92
  start-page: 1746
  issue: 9
  year: 2005
  ident: 4480_CR35
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602534
– volume: 23
  start-page: 609
  issue: 3
  year: 2005
  ident: 4480_CR25
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.01.086
– volume: 28
  start-page: 3219
  issue: 20
  year: 2010
  ident: 4480_CR18
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.27.1825
– volume: 103
  start-page: 863
  issue: 11
  year: 2011
  ident: 4480_CR20
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djr153
– volume: 177
  start-page: 2688
  issue: 6
  year: 2010
  ident: 4480_CR23
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2010.100298
– volume: 53
  start-page: 1535
  issue: 12
  year: 2018
  ident: 4480_CR24
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2018.1542453
– volume: 37
  start-page: 1831
  issue: 4
  year: 2017
  ident: 4480_CR22
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.11518
– ident: 4480_CR33
  doi: 10.1200/jco.2009.27.15_suppl.4002
SSID ssj0017674
Score 2.3841908
Snippet Purpose About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability...
About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability (MSI)....
Purpose About 10 to 15% of patients with sporadic colorectal cancer display mutations in DNA mismatch repair (MMR) genes shown as microsatellite instability...
SourceID swepub
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 197
SubjectTerms Analysis
Cancer
Cancer patients
Colorectal cancer
Colorectal Neoplasms - surgery
Comorbidity
DNA Mismatch Repair - genetics
Gastroenterology
Genetic aspects
Health aspects
Hepatology
Humans
Immunohistochemistry
Internal Medicine
Medical records
Medicine
Medicine & Public Health
Microsatellite Instability
Microsatellite Repeats
Mortality
Neoplasm Recurrence, Local
Oncology, Experimental
Proctology
Prognosis
Surgery
Sweden - epidemiology
Title The prognostic significance of microsatellite instability in colorectal cancer: a Swedish multi-center study
URI https://link.springer.com/article/10.1007/s00384-023-04480-z
https://www.ncbi.nlm.nih.gov/pubmed/37458848
https://www.proquest.com/docview/2839246685
https://pubmed.ncbi.nlm.nih.gov/PMC10352163
http://kipublications.ki.se/Default.aspx?queryparsed=id:153300967
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB6aBEovpe-6SRcVSntoBZIs-dHbsiQNLemlXUhPwpJlEpp4w-6G0vz6zGhtUy8l0JuxJFv2jGZGzDefAN6WomyEK1OOoWjDdVkLXuhUcenTqsRdUOpzKhQ--ZYdz_WXU3PaFYWterR7n5KMlnoodqMkluboY7jAPYXgNzuwZ3DvTkCuuZoOuQOip-nKY_49buSCtg3xX55oGyU5pEq3aEWjKzp6BA-7GJJNN0J_DPdC-wTun3RZ8qdwgbJnBLxqF8TCzAijQYggEjBbNOySQHirKnJxrgM7pwgxYmT_4DUjGmsyg_iGOGL5iVXs-2-q3z1jEX_Iaa5hySI17TOYHx3-mB3z7lQF7o1Ra57lQbq6lrXWeZEWFUZATjrnRe60QFdlTCMqKlhNy0Y7aYpaq6Cc17VUSuiQPofddtGGl8CcwZ_jG6JIy3RVmbIxVVE3QRo0mrlRCcj-R1vfUY7TyRcXdiBLjsKxKBwbhWNvEvgwjLnaEG7c2fs9yc_SasQn-6orKsD5Ea-VneYYjtJhTDiXg1FPXEV-1Pym1wBLTQQ9a8PiemUVhZA6ywqTwIuNRgwTS_NY6FskUIx0ZehA5N3jlvb8LJJ4SyKixWA4gY-9WtnOfKzu_OB3G9UbvaK79QuvgqVUbKFe_d9z9-GBikuEKEMPYHe9vA6vMdxauwnsTT___Ho4gZ1ZNpvEtXYLNzcniw
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fa9swED62FLa9lP3svHabBmN72AS2LNly38JYybKmL22hb8KyZVrWOSVJKetf3ztFNnMYhb0ZS7Jl3-nuxH33CeBjERdNbIuUYyjacFnUMdcyFTyp0rLAXVBa5VQoPDvKJqdyeqbOQlHYskO7dylJb6n7YjdKYkmOPobHuKeI-e1D2NIq02oEW-Px9HjaZw-IoCYUyPx75MAJbZriv3zRJk6yT5ZuEIt6Z3TwFLZDFMnGa7E_gweufQ6PZiFP_gIuUfqMoFftnHiYGaE0CBNEImbzhv0mGN6y9GycK8cuKEb0KNk_eM2IyJoMIb7Bj1jss5Id31AF7znzCEROc3UL5slpX8LpwfeTbxMezlXglVJixbPcJbauk1rKXKe6xBjIJtZWcW5ljM5KqSYuqWQ1LRppE6VrKZywlawTIWLp0lcwauetew3MKvw5VUMkaZksS1U0qtR14xKFZjNXIoKk-9GmCqTjdPbFpenpkr1wDArHeOGY2wi-9GOu1pQb9_b-TPIztB7xyVUZygpwfsRsZcY5BqR0HBPOZW_QE9dRNWj-0GmAoSYCn7Vufr00goJImaGmRbCz1oh-YmnuS311BHqgK30Hou8etrQX557GOyEqWgyHI_jaqZUJBmR57wd_Wqve4BXh1i-8coaSsVq8-b_nvofHk5PZoTn8cfRzF54Iv1yIQHQPRqvFtXuLwdfKvgtr7Q7pdilZ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZtCqGX0HedR6tCaQ-tiC1Ltpzb0nZJHwmFdiE3IckSCU28YdehNL--M7LXxEsJ9GZWkq31jDRj5vs-EfK6SquQ2ipnkIoGJqo6ZUrknGUuNxV8BeWuRKLw0XFxOBNfTuTJDRZ_RLuvSpIdpwFVmpp2_7IO-wPxDQtagkG8YSl8X6Ts-i65J5ANDB4945OhjoBSNT1V5t_jRuFofVO-EZXWEZND2XRNYjSGpekDstXnk3TSOcBDcsc3j8jmUV8xf0zOwQ8ogrCaOSoyU8RrIDoIjU3ngV4gIG9poi5n6-kZZosRL_sHrilKWuOWCE-IIxYH1NAfv5HLe0ojFpHhXP2CRpnaJ2Q2_fTzwyHrT1hgTkresqL0ma3rrBaiVLkykA3ZzFqXllakELakDKlB8mpeBWEzqWrBPbdO1BnnqfD5U7LRzBv_nFAr4eW4gHJphTBGVkEaVQefSdhAS8kTkq1etHa9_DiegnGuB-HkaBwNxtHROPo6Ie-GMZed-Matvd-i_TSuTLizMz3BAOaHGld6UkJqigczwVx2Rz1hRblR86uVB2hsQhha4-dXS80xnRRFoWRCnnUeMUwsLyPpVyVEjXxl6IBC3uOW5uw0CnpnKEoLiXFC3q_cSvdbyfLWP_ymc73RI_qffsGV11iWVXz7_-77kmx-_zjV3z4ff90h93lcLagkuks22sWV34MsrLUv4kL7C1cxLEA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+prognostic+significance+of+microsatellite+instability+in+colorectal+cancer%3A+a+Swedish+multi-center+study&rft.jtitle=International+journal+of+colorectal+disease&rft.au=Rantanen%2C+Petri&rft.au=Ker%C3%A4nen%2C+Anne&rft.au=Barot%2C+Shabane&rft.au=Ghazi%2C+Sam&rft.date=2023-07-17&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0179-1958&rft.eissn=1432-1262&rft.volume=38&rft.issue=1&rft_id=info:doi/10.1007%2Fs00384-023-04480-z&rft_id=info%3Apmid%2F37458848&rft.externalDocID=PMC10352163
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1432-1262&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1432-1262&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1432-1262&client=summon